DSM Biomedical showed a strong increase in sales versus Q1 2012, mainly due to the contribution of Kensey Nash (EUR19 million).

VOLCANO CORPORATION INKS AGREEMENT TO ACQUIRE CRUX BIOMEDICAL IMPEDANCE CARDIOGRAPHY SET TO REPLACE HUT FOR VASOVAGAL SYNCOPE DIAGNOSIS EDWARDS LIFESCIENCES RECEIVES CHINA'S SFDA APPROVAL FOR PERIMOUNT MITRAL HEART ... THORATEC INTRODUCES THORATEC ...